Flow Cytometry is the primary tool in most immunology laboratories for the detailed characterization of lymphocytes and lymphocyte function. The ability to resolve highly complex populations of cells, interrogate the cells one-by-one, make multiple measurements on each cell, and then separate the cells viably for further study make this technology unique and indispensable. Our laboratory has long been involved in pushing this technology forward;we have perhaps the most sophisticated flow cytometer in the world, currently capable of making 20 different measurements on each cell. This platform has proven invaluable in dissecting immune responses to vaccines and viruses. In addition, we are developing novel algorithms for the automated analysis of the highly complex data that results from these experiments.

Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
2013
Total Cost
$1,168,546
Indirect Cost
City
State
Country
Zip Code
Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure et al. (2016) Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS One 11:e0153484
Fletez-Brant, Kipper; Špidlen, Josef; Brinkman, Ryan R et al. (2016) flowClean: Automated identification and removal of fluorescence anomalies in flow cytometry data. Cytometry A 89:461-71
Roederer, Mario (2016) Distributions of autofluorescence after compensation: Be panglossian, fret not. Cytometry A 89:398-402
Beddall, Margaret; Chattopadhyay, Pratip K; Kao, Shing-Fen et al. (2016) A simple tube adapter to expedite and automate thawing of viably frozen cells. J Immunol Methods 439:74-78
Szomolay, Barbara; Liu, Jie; Brown, Paul E et al. (2016) Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors. Immunol Cell Biol 94:573-82
Kibuuka, Hannah; Berkowitz, Nina M; Millard, Monica et al. (2015) Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet 385:1545-54
Shen, Xiaoying; Duffy, Ryan; Howington, Robert et al. (2015) Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates. J Virol 89:8643-50
Roederer, Mario (2015) Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models. PLoS Pathog 11:e1005100
Saunders, Kevin O; Wang, Lingshu; Joyce, M Gordon et al. (2015) Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection. J Virol 89:8334-45
Roederer, Mario; Quaye, Lydia; Mangino, Massimo et al. (2015) The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell 161:387-403

Showing the most recent 10 out of 49 publications